BXPBXP, Inc.
Is the price fair?
In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In its normal range: P/E 31.7 vs a 27.2 median over 37 quarters (+17% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What BXP's price assumes
BXP, Inc. trades at 31.7× earnings against 33.1× for the median REIT - Office name, cheaper than its own group.
Trailing P/E · REIT - Office median 33.1 · cheaper than the typical name in its group
- Price / sales
- 2.91
Price / sales · as of 2026-Q2
- Price / book
- 1.99
Price / book · as of 2026-Q2
- EV / sales
- 4.19
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.99
- EV / EBITas of 2026-Q2
- 52.2
- EV / salesas of 2026-Q2
- 4.19
- Real Estate median P/E130 names
- 25.0
- REIT - Office median P/E10 names
- 33.1
- Market capitalisation
- $11.5B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $40.24 |
| Its own P/E history, median | $50.63 |
| Its own P/E history, upper quartile | $60.08 |
| 52-week range | $50.74 – $74.53 |
| Today | $59.04 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
REIT, Office
The closest names by size in the same industry